TrademarkDir
ALLYX THERAPEUTICS
LIVE

Serial Number

97282621

Owner

Allyx Therapeutics, Inc.

Attorney

Glenn M. Cunningham

Filing Date

Feb 24, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ALLYX THERAPEUTICS Trademark

Serial Number: 97282621

ALLYX THERAPEUTICS is a trademark filed by Allyx Therapeutics, Inc. on February 24, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Allyx Therapeutics, Inc. (3 trademarks)

470 James St., Suite 007
New Haven, CT 06513

Entity Type: 03

Trademark Details

Filing Date

February 24, 2022

Registration Date

Not Registered

Published for Opposition

January 17, 2023

Goods & Services

Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, but not including products for the treatment of hemophilia

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jun 2, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 1, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Jan 7, 2026 EEXT
SOU EXTENSION 5 FILED
Jan 6, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 16, 2025 EX4G
SOU EXTENSION 4 FILED
May 15, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 9, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 9, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 9, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 31, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 31, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 31, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 31, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 31, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 9, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 9, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 9, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 3, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 3, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 3, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 11, 2023 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 28, 2023 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Apr 18, 2023 CHPB
ASSIGNED TO PETITION STAFF
Apr 17, 2023 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 31, 2023 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 10, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 14, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 14, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 14, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 14, 2022 CNEA
ASSIGNED TO EXAMINER
Dec 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2022 NWOS
NEW APPLICATION ENTERED
Feb 28, 2022 NWAP

Related Trademarks

More from this Owner

ALLYX THERAPEUTICS

ALLYX THERAPEUTICS

ALLYX THERAPEUTICS

ALLYX THERAPEUTICS

ALLYX THERAPEUTICS

ALLYX THERAPEUTICS

ALLYX THERAPEUTICS

ALLYX THERAPEUTICS